Laurie Glimcher trained at Massachusetts General Hospital. Her father was the chair of orthopedic surgery there, and her son is currently a thoracic surgeon at the hospital.
But Glimcher, the CEO of the neighboring Dana-Farber Cancer Institute, has no qualms about the contentious decision to sever a 30-year partnership with Massachusetts General’s parent organization.
The move will turn Dana-Farber and Mass General Brigham into competitors for cancer patients in the Boston area, and at the annual STAT Summit in Boston Wednesday, Glimcher asserted that it is actually a good change for patients, one that will lead to lower costs and help the region address the rising rates of cancer in an aging population.